96660 ⎘
Peptides of undefined number of amino acids; Derivatives thereof
TARGETED DRUG CONJUGATE, MEDICINE INCLUDING SAME, AND COMPOUND
#2NOVEL PHAGE LIBRARIES OF BICYCLIC PEPTIDES
#3METHODS, PLANTS AND COMPOSITIONS FOR OVERCOMING NUTRIENT SUPPRESSION OF MYCORRHIZAL SYMBIOSIS
#4NUCLEIC ACID CLOSING POLYMERIC MICELLE
#5Neurotoxin Compositions with Increased Efficacy and Effect Duration
#6Method for Manufacturing Biosensor
#7Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer
#8Neoantigens Expressed In Ovarian Cancer And Their Uses
#9METHODS, PLANTS AND COMPOSITIONS FOR OVERCOMING NUTRIENT SUPPRESSION OF MYCORRHIZAL SYMBIOSIS
#10PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS
#11MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS
#12PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
#13SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#14COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY
#15COMPOSITIONS AND METHODS OF CELL ATTACHMENT
#16POLYPEPTIDES AND METHODS
#17Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing
#18MULTIMERIC BICYCLIC PEPTIDE LIGANDS
#19PEPTIDE NUCLEIC ACID CONJUGATES
#20COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY
#21COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID
#22METHOD TO GENERATE BIOCHEMICALLY REACTIVE AMINO ACIDS
#23System and process for increasing protein product yield from bacterial cells
#24SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#25MODULATION OF ANTIGEN IMMUNOGENICITY BY ADDITION OF EPITOPES RECOGNIZED BY NKT CELLS
#26CYSTEINE BINDING COMPOSITIONS AND METHODS OF USE THEREOF
#27PEPTIDE FOR TREATING INFLAMMATION AND WOUNDS
#28SULFUR-HETEROCYCLE EXCHANGE CHEMISTRY AND USES THEREOF
#29CONDITIONALLY ACTIVE HETERODIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#30Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine
#31Fusion Peptide for Forming Virus-Like Particle
#32N- and C-terminal tandem tag system for purification
#33Carrier Peptide Fragment and use Thereof
#34SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#35Tertiary amino lipidated cationic peptides for nucleic acid delivery
#36Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
#37MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT CELLS
#38Hepatitis B virus replication inhibitor and pharmaceutical composition for treating hepatitis B comprising the same
#39TERTIARY AMINO LIPIDATED CATIONIC PEPTIDES FOR NUCLEIC ACID DELIVERY
#40ANTI-SAS1B ANTIBODIES, ASSOCIATED METHODS OF USE, AND COMPOSITIONS AND METHODS FOR DETECTING AND TREATING CANCER
#41Neoantigens expressed in ovarian cancer and their uses
#42Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
#43Modulation of structured polypeptide specificity
#44Polypeptides Capable of Forming Homo-Oligomers with Modular Hydrogen Bond Network-Mediated Specificity and Their Design
#45Multimeric bicyclic peptide ligands
#46Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#47Sulfur (VI) fluoride compounds and methods for the preparation thereof
#48PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS
#49Methods of incorporating an amino acid comprising a BCN group into a polypeptide using an orthogonal codon encoding it and an orthogonal pylrs synthase
#50Arylfluorosulfate compounds and methods
#51Cultured phagocyte supernatent compositions
#52Heterodimeric antibodies that bind CD3 and PSMA
#53Proteins for the treatment of epithelial barrier function disorders
#54MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS
#55Proteins for the treatment of epithelial barrier function disorders
#56CYCLIC PEPTIDE COMPOUND HAVING HIGH MEMBRANE PERMEABILITY, AND LIBRARY CONTAINING SAME
#57Mussel adhesive protein product and use thereof for treating mucosal inflammation
#58Peptide nucleic acid conjugates
#59NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#60Peptide-based multiple-drug delivery vehicle
#61DNA-peptide composite comprising high-density functional group, DNA-peptide-nanomaterial composite and preparation method therefor, and DNA-metal nanowire and manufacturing method therefor
#62Lin28-mediated control of let-7 biogenesis
#63Compact and homogeneous quantum dots and methods of making the same
#64Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
#65Composition for obtaining protein-rich nutrient supplements from bacterial fermentation process
#66System and process for increasing protein product yield from bacterial cells
#67System for obtaining protein-rich nutrient supplements from bacterial fermentation process
#68SCALABLE MANUFACTURING PLATFORM FOR VIRAL VECTOR PURIFICATION AND VIRAL VECTORS SO PURIFIED FOR USE IN GENE THERAPY
#69SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#70Walnut oligopeptide powder, preparation method and application thereof
#71Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid
#72Multimeric bicyclic peptide ligands
#73MULTI-DIMENSIONAL STRUCTURES FROM PEPTOID OLIGOMERS AND METHODS OF MAKING
#74ANTI-SAS1B ANTIBODIES, ASSOCIATED METHODS OF USE, AND COMPOSITIONS AND METHODS FOR DETECTING AND TREATING CANCER
#75Method of Producing Polyamide Material with Peptides and Polyamide Material with Peptides
#76COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR USE IN MEDICINE
#77Ribosome display complex and production method therefor
#78ARYLFLUOROSULFATE COMPOUNDS AND METHODS
#79Peptides having tetrahedral mimicking groups as inhibitors of rhomboid proteases
#80Purification of glucagon-like peptide 1 analogs
#81Polypeptdes capable of forming homo-oligomers with modular hydrogen bond network-mediated specificity and their design
#82Sulfur(VI) fluoride compounds and methods for the preparation thereof
#83ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS
#84Fibroin-Like Protein Variant and Cell Culture Method
#85Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer
#86Method for fabricating two-dimensional protein crystals
#87Cyclin-dependent kinase substrate
#88Proteins for the treatment of epithelial barrier function disorders
#89LIN28- MEDIATED CONTROL OF LET-7 BIOGENESIS
#90NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#91Peptide-based multiple-drug delivery vehicle
#92Mussel adhesive protein product and use thereof for treating mucosal inflammation
#93Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#94Carbonyl reductase oligomers and their application in synthesis of chiral alcohols
#95Coupled peptide chain for dissolving poorly soluble polypeptides and application thereof for separation and purification in liquid chromatography
#96HYBRID FLAGELLIN AS A T CELL INDEPENDENT VACCINE SCAFFOLD
#97Methods and compositions for treatment of a genetic condition
#98MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS
#99Methods and compositions for treatment of a genetic condition
#100Method and electronic system for predicting at least one fitness value of a protein, related computer program product
#101Amphiphilic nanoparticles for delivery of CRISPR based therapy
#102Method for preparing site-specifically modified protein based on novel carbon-carbon bond formation
#103Compositions and methods of cell attachment
#104Compositions and methods of cell attachment
#105Compositions and methods of cell attachment
#106Compositions and methods of cell attachment
#107Compositions and methods of cell attachment
#108Cell culture method, cell aggregates, cell aggregation control agent, and medium
#109Compositions and methods of cell attachment
#110Polymer compound which has membrane-permeable peptide in side chain
#111Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#112Nanoparticle conjugates of highly potent toxins and intraperitoneal administration of nanoparticles for treating or imaging cancer
#113JC polyomavirus VLP (virus-like particle) with a targeting peptide
#114PREDICTIVE MARKER FOR TOPOISOMERASE I INHIBITORS
#115AMPHIPHILIC NANOPARTICLES FOR CODELIVERY OF WATER-INSOLUBLE SMALL MOLECULES AND RNAi
#116AQUEOUS PEPTIDE-STABILIZED POLYURETHANE DISPERSIONS
#117Artificial multi-antigen fusion protein and preparation and use thereof
#118Heterodimeric antibodies that bind CD3 and PSMA
#119Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#120Activated carbon for the removal of leachables and/or extractables
#121ANTIMICROBIAL AGENTS
#122Conditionally active heterodimeric polypeptides and methods of use thereof
#123Method for preparing glatiramer acetate
#124Incretin-insulin conjugates
#125BLOCKING PIRB UPREGULATES SPINES AND FUNCTIONAL SYNAPSES TO UNLOCK VISUAL CORTICAL PLASTICITY AND FACILITATE RECOVERY FROM AMBLYOPIA
#126Endoplasmic Reticulum Localization Signals
#127Peptide with safer secondary structure, peptide library, and production methods for same
#128PREVENTION OF TUMOUR METASTASIS BY INHIBITION OF NECROPTOSIS
#129Sulfur(VI) fluoride compounds and methods for the preparation thereof
#130Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#131Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby
#132Enhanced nucleic acid constructs for eukaryotic gene expression
#133Methods and Compositions Employing a Sulfonylurea-Dependent Stabilization Domain
#134Method for continuous production of degradation product of water-insoluble polymeric compound
#135HYDROLYSATE OF ANIMAL PROTEIN, MANUFACTURING METHOD THEREOF AND USE THEREOF
#136NON-RIBOSOMAL PROTEIN SYNTHESIS PIGMENT FUSION PEPTIDES
#137Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
#138Water-soluble expression and purification method of human GCSF recombinant protein having biological activities
#139Ligands to radiation-induced molecules
#140Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#141Materials and Methods Relating to Pancreatic Cancer
#142CATALYST AND RELATED METHODS
#143Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#144Method for inactivating target transcription factor using artificial small interfering peptide and use thereof
#145Analyte mass spectrometry quantitation using a universal reporter
#146Methods and compositions for treatment of a genetic condition
#147Endoplasmic reticulum localization signals
#148Functionalized naphthalene fluorophores
#149Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#150Synthesis, structure and use of functionalized naphthalenes
#151Chelates, chelating agents, conjugates derived thereof and their use
#152METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTION
#153System and Method for Visualization of Optimized Protein Expression
#154Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
#155NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM
#156Method of Detecting and Treating Tuberous Sclerosis Complex Associated Disorders
#157Predictive marker for topoisomerase I inhibitors
#158Split inteins and uses thereof
#159Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
#160Peptide inhibitors as novel anti-HIV therapeutics
#161Translocation of non-natural chemical entities through anthrax protective antigen pore
#162Modulation of TLR4-signaling pathway
#163Protein retrosplicing enabled by a double ligation reaction
#164Immunogenic composition and uses thereof
#165METHODS OF INCORPORATING AN AMINO ACID COMPRISING A BCN GROUP INTO A POLYPEPTIDE USING AN ORTHOGONAL CODON ENCODING IT AND AN ORTHORGONAL PYLRS SYNTHASE
#166AMINO ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS
#167Analyte mass spectrometry quantitation using a universal reporter
#168Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
#169Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#170Antigen delivery vectors and constructs
#171Controlled synthesis of polyglutamates with low polydispersity and versatile architectures
#172Nutritive fragments, proteins and methods
#173MENA AND ALPHA5 INTEGRIN INTERACTION
#174Methods and compositions for treatment of a genetic condition
#175Solid State Fermentation Systems and Process for Producing High-Quality Protein Concentrate and Lipids
#176Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#177Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells
#178NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#179Endoplasmic reticulum localization signals
#180Milk-fermented product and use thereof
#181Molecules with extended half-lives, compositions and uses thereof
#182Nucleic acids encoding synthetic scaffolds and host cells genetically modified with the nucleic acids
#183Ligands to radiation-induced molecules
#184RADIATION EXPOSURE DIAGNOSTIC MARKER IGFBP-5, COMPOSITION FOR RADIATION EXPOSURE DIAGNOSIS BY MEASURING THE EXPRESSION LEVEL OF THE MARKER, RADIATION EXPOSURE DIAGNOSTIC KIT COMPRISING THE COMPOSITION, AND METHOD FOR DIAGNOSING RADIATION EXPOSURE USING THE MARKER
#185Lin28-mediated control of let-7 biogenesis
#186Compositions and methods for cancer and cancer stem cell detection and elimination
#187Modulation of structured polypeptide specificity
#188Modulation of structured polypeptide specificity
#189Enzyme-degradable polymer and application thereof
#190Immunogenic compositions against human progastrin peptides
#191Compositions and methods for treatment of cancer
#192Recombinant protein, pharmaceutical composition containing the same, and method of biosynthesizing
#193Method for determining an unknown PNA sequence and uses thereof
#194Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
#195AFFINITY TAGS ABLE TO DETECT FRAMESHIFTS
#196Mimotopic Peptides for the Diagnosis and Treatment of Multiple sclerosis
#197METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS
#198Novel milk-fermented product and use thereof
#199ANTIMICROBIAL AGENTS
#200Transducible Polypeptides for Modifying Metabolism
#201Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#202IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
#203Unnatural amino acids comprising a cyclooctynyl or trans-cyclooctenyl analog group and uses thereof
#204NOVEL POLYMAVIRUS ASSOCIATED WITH DIARRHEA IN CHILDREN
#205Evaluation of copolymer diethylamide
#206Nanoparticles containing pH-responsive peptide
#207Method for regulating neurite growth
#208ANGIOTENSIN CONVERTING ENZYME INHIBITORY PEPTIDE
#209Composite probes and use thereof in super resolution methods
#210Copolymer-1, process for preparation and analytical methods thereof
#211Peptide with safer secondary structure, peptide library, and production methods for same
#212Functionalized naphthalene fluorophores
#213Synthesis, structure and use of functionalized naphthalenes
#214Glycogen synthase kinase-3 inhibitors
#215AXMI-192 FAMILY OF PESTICIDAL GENES AND METHODS FOR THEIR USE
#216Modulation of antigen immunogenicity by addition of epitopes recognized by NKT cells
#217Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#218Pharmaceutical composition for preventing or treating Th17-mediated disease comprising poly-gamma-glutamic acid
#219Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
#220Endoplasmic reticulum localization signals
#221Formulation and delivery of PLGA microspheres
#222Ligands to radiation-induced molecules
#223Formulation and delivery of PLGA microspheres
#224Split dose administration
#225METHOD FOR INCREASING THE PRODUCTION OF A PROTEIN OF INTEREST
#226METHOD FOR PREVENTING HIV-1 INFECTION OF CD4+ CELLS
#227Proteolytically resistant hydrogen bond surrogate helices
#228Analyte mass spectrometry quantitation using a universal reporter
#229HUMAN PAPILLOMAVIRUS E7 ANTIGEN COMPOSITIONS AND USES THEREOF
#230Glatiramer acetate molecular weight markers
#231Method for constructing libraries of non-standard peptide compounds comprising N-methyl amino acids and other special (non-standard) amino acids and method for searching and identifying active species
#232DIPEPTIDE LINKED MEDICINAL AGENTS
#233MODIFIED POLYPEPTIDES AND PROTEINS AND USES THEREOF
#234Analyte mass spectrometry quantitation using a universal reporter
#235Vaccine for enveloped viruses
#236Thiosulfonate compound, reversible cationization agent for protein and/or peptide, and method for solubilization
#237Method for Determining the Concentration of a Peptide
#238Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#239Sialic acid (A-(2-6))-D-aminopyranose derivatives, synthesis methods and uses thereof
#240Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#241INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTORS AND METHODS OF USE THEREOF
#242Immunogenic compositions against human progastrin peptides
#243Molecules with extended half-lives, compositions and uses thereof
#244METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS
#245Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#246Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#247Antigen delivery vectors and constructs
#248Composite probes and use thereof in super resolution methods
#249Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope
#250Nucleic acids and proteins and methods for making and using them
#251Compounds and methods for purifying peptides produced by solid phase peptide synthesis
#252Method of detecting and treating tuberous sclerosis complex associated disorders
#253ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS
#254Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives
#255Solid phase peptide synthesis of peptide alcohols
#256Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
#257IMMUNOGENIC COMPOSITION AND USES THEREOF
#258ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS
#259Antigen delivery vectors and constructs
#260Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
#261Multiplexed olfactory receptor-based microsurface plasmon polariton detector
#262Molecules with extended half-lives, compositions and uses thereof
#263Ligands to radiation-induced molecules
#264Endoplasmic reticulum localization signals
#265Peptide Fibres
#266Angiotensin converting enzyme inhibitory peptide
#267Pipecolic linker and its use for chemistry on solid support
#268Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
#269Stabilized liquid enzyme compositions
#270AXMI-192 family of pesticidal genes and methods for their use
#271Predictive marker for topoisomerase I inhibitors
#272Use of synthetic scaffolds for the production of biosynthetic pathway products
#273Peptidomimetic macrocycles with improved properties
#274Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
#275Compositions and methods for treatment of cancer
#276Molecules with extended half-lives, compositions and uses thereof
#277Antigen delivery vectors and constructs
#278Antigen delivery vectors and constructs
#279Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
#280Method for determining an unknown PNA sequence and uses thereof
#281Nucleic acids and proteins and methods for making and using them
#282Nucleosides with antiviral and anticancer activity
#283METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS
#284TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM
#285Process for the preparation of a polypeptide
#286Composite material useful as biomaterial and its preparation
#287Method for regulating neurite growth
#288Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#289Method of detecting and treating tuberous sclerosis complex associated disorders
#290Endoplasmic reticulum localization signals
#291High-pressure inclusion body solubilization and protease clipping of recombinant fusion proteins
#292Anti-Viral Effect of an Extract of Ganoderma Lucidum
#293Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#294Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#295CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
#296Methods for determining effectiveness of waste water tank deodorizers and synthetic waste compositions for use in said methods
#297Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#298Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
#299Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
#300Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions